Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Mark Boguniewicz

Concepts (517)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Dermatitis, Atopic
151
2024
310
22.530
Why?
Eczema
14
2023
82
3.150
Why?
Antibodies, Monoclonal, Humanized
17
2023
665
2.420
Why?
Skin
32
2024
659
2.010
Why?
Severity of Illness Index
43
2023
2551
1.900
Why?
Tacrolimus
20
2023
135
1.850
Why?
Pruritus
15
2023
60
1.520
Why?
Dermatologic Agents
13
2023
57
1.500
Why?
Antibodies, Monoclonal
7
2023
1268
1.460
Why?
Quality of Life
27
2023
2359
1.360
Why?
Immunosuppressive Agents
14
2023
651
1.240
Why?
Staphylococcus aureus
11
2023
385
1.160
Why?
Staphylococcal Skin Infections
6
2018
29
1.160
Why?
Receptors, Aryl Hydrocarbon
2
2024
39
1.120
Why?
Keratinocytes
11
2024
216
1.110
Why?
Biological Products
2
2020
171
1.110
Why?
Asthma
15
2023
2051
1.040
Why?
Calcineurin Inhibitors
14
2010
58
0.980
Why?
Kaposi Varicelliform Eruption
12
2013
24
0.950
Why?
Humans
170
2024
115049
0.870
Why?
Practice Guidelines as Topic
9
2018
1398
0.860
Why?
Boron Compounds
3
2018
17
0.770
Why?
Immunoglobulin E
18
2023
323
0.760
Why?
Emollients
4
2018
11
0.740
Why?
Urticaria
3
2008
50
0.740
Why?
Double-Blind Method
23
2023
1665
0.730
Why?
Interleukin-4 Receptor alpha Subunit
1
2020
7
0.730
Why?
Hypersensitivity
3
2023
256
0.720
Why?
Intermediate Filament Proteins
7
2018
65
0.700
Why?
Bridged Bicyclo Compounds, Heterocyclic
3
2018
172
0.690
Why?
Adrenal Cortex Hormones
10
2023
499
0.670
Why?
Dermatology
3
2017
86
0.670
Why?
Bandages
3
2016
31
0.660
Why?
Administration, Topical
15
2020
138
0.650
Why?
Cytokines
16
2023
1843
0.650
Why?
Anti-Infective Agents
5
2022
225
0.650
Why?
Allergy and Immunology
2
2017
53
0.640
Why?
Expert Testimony
1
2019
36
0.640
Why?
Anti-Inflammatory Agents
11
2020
451
0.630
Why?
Skin Care
4
2008
18
0.620
Why?
Interferon-gamma
11
2013
723
0.610
Why?
Adult
71
2023
30658
0.600
Why?
Treatment Outcome
29
2023
9123
0.600
Why?
Biological Therapy
1
2017
26
0.580
Why?
Interleukin-13
10
2023
123
0.570
Why?
Occlusive Dressings
1
2016
5
0.560
Why?
Antimicrobial Cationic Peptides
5
2010
75
0.550
Why?
Interleukin-4
9
2023
209
0.520
Why?
Herpes Simplex
3
2013
87
0.520
Why?
Advisory Committees
1
2017
208
0.510
Why?
Psoriasis
10
2023
74
0.510
Why?
Anti-Asthmatic Agents
1
2019
350
0.490
Why?
Cost of Illness
9
2018
254
0.490
Why?
Education, Medical, Continuing
1
2016
119
0.480
Why?
Epidermis
3
2017
149
0.470
Why?
Conjunctivitis
3
2023
17
0.450
Why?
Cyclic Nucleotide Phosphodiesterases, Type 4
3
2018
6
0.450
Why?
Simplexvirus
3
2011
80
0.450
Why?
Autoimmune Diseases
4
2018
394
0.450
Why?
Glycyrrhetinic Acid
3
2008
7
0.450
Why?
Th2 Cells
6
2017
155
0.440
Why?
Molecular Targeted Therapy
2
2020
347
0.440
Why?
Anti-Allergic Agents
3
2014
41
0.430
Why?
Child
40
2023
18407
0.420
Why?
Hypersensitivity, Immediate
3
2019
46
0.420
Why?
Calcineurin
5
2006
89
0.410
Why?
Desensitization, Immunologic
4
2022
117
0.410
Why?
beta-Defensins
7
2010
18
0.410
Why?
Child, Preschool
30
2018
9093
0.400
Why?
Immunity, Innate
6
2011
723
0.390
Why?
Anti-Inflammatory Agents, Non-Steroidal
4
2015
299
0.380
Why?
Allergens
7
2023
417
0.360
Why?
Adolescent
33
2023
17864
0.350
Why?
Drug Approval
3
2020
78
0.350
Why?
Ointments
10
2016
23
0.350
Why?
Clinical Trials as Topic
4
2020
937
0.350
Why?
Food Hypersensitivity
5
2018
254
0.350
Why?
Adaptive Immunity
1
2011
156
0.350
Why?
Plant Extracts
3
2008
154
0.350
Why?
Disease Progression
6
2019
2389
0.340
Why?
Complementary Therapies
1
2010
72
0.340
Why?
Methicillin-Resistant Staphylococcus aureus
1
2012
191
0.340
Why?
Staphylococcal Infections
4
2023
336
0.330
Why?
Dietary Fats
2
2008
290
0.330
Why?
Drug Hypersensitivity
3
1995
85
0.320
Why?
Off-Label Use
2
2020
52
0.320
Why?
Prevalence
12
2019
2255
0.320
Why?
Inflammation
4
2018
2485
0.310
Why?
Receptors, IgE
1
2008
40
0.310
Why?
Administration, Cutaneous
8
2016
117
0.310
Why?
Population Groups
2
2018
57
0.310
Why?
Male
51
2023
55735
0.300
Why?
Chronic Disease
12
2019
1591
0.300
Why?
Self Report
7
2019
698
0.300
Why?
Disease Management
5
2020
563
0.290
Why?
United States
19
2023
12227
0.290
Why?
Cross-Sectional Studies
14
2021
4411
0.270
Why?
Anti-Bacterial Agents
6
2023
1477
0.270
Why?
Female
49
2023
59617
0.260
Why?
Dermatitis, Allergic Contact
2
2016
63
0.250
Why?
Vaccinia virus
4
2011
28
0.250
Why?
Patch Tests
3
2016
52
0.250
Why?
Phototherapy
3
2018
24
0.250
Why?
Infant
22
2022
7946
0.240
Why?
Omalizumab
2
2020
46
0.240
Why?
Steroids
3
2017
147
0.240
Why?
Exanthema
1
2005
76
0.230
Why?
Diagnosis, Differential
7
2008
1355
0.230
Why?
Anxiety
3
2019
845
0.230
Why?
Janus Kinase Inhibitors
1
2023
10
0.230
Why?
Middle Aged
34
2019
26830
0.220
Why?
Janus Kinases
1
2023
12
0.220
Why?
Ectropion
1
2023
2
0.220
Why?
Blepharitis
1
2023
3
0.220
Why?
Down-Regulation
7
2017
599
0.220
Why?
Pain
2
2019
709
0.220
Why?
Sublingual Immunotherapy
1
2022
7
0.210
Why?
Receptors, Interleukin
3
2020
39
0.210
Why?
Depression
3
2019
1136
0.200
Why?
Tight Junctions
3
2011
68
0.200
Why?
Sickness Impact Profile
2
2019
50
0.200
Why?
Recurrence
4
2019
941
0.200
Why?
Drug Industry
2
2018
104
0.190
Why?
STAT6 Transcription Factor
3
2011
22
0.190
Why?
Membrane Proteins
4
2011
1019
0.190
Why?
Patient Education as Topic
5
2015
682
0.180
Why?
Autoantibodies
1
2008
1354
0.180
Why?
Sleep Initiation and Maintenance Disorders
1
2022
117
0.180
Why?
Consensus
3
2017
534
0.180
Why?
Bacterial Toxins
3
2012
103
0.180
Why?
Biomarkers
6
2023
3419
0.180
Why?
Animals
16
2023
31868
0.170
Why?
Injections, Subcutaneous
4
2023
133
0.170
Why?
Pyrimidines
1
2022
376
0.170
Why?
Skin Diseases, Infectious
3
2008
15
0.160
Why?
Patient Health Questionnaire
1
2018
20
0.160
Why?
Sulfonamides
1
2022
446
0.160
Why?
Surveys and Questionnaires
5
2019
4631
0.160
Why?
Phosphodiesterase Inhibitors
1
2018
82
0.160
Why?
Randomized Controlled Trials as Topic
5
2023
1215
0.150
Why?
Injections
1
2019
159
0.150
Why?
Patient Reported Outcome Measures
4
2022
250
0.150
Why?
Genetic Predisposition to Disease
6
2011
2108
0.150
Why?
T-Lymphocytes
6
2006
1747
0.150
Why?
Sleep Wake Disorders
1
2021
232
0.150
Why?
Immunologic Factors
2
2005
221
0.150
Why?
Guidelines as Topic
2
2018
245
0.150
Why?
Gene Expression Regulation
6
2011
2329
0.140
Why?
Skin Diseases
1
2019
122
0.140
Why?
Practice Patterns, Physicians'
2
2017
1178
0.140
Why?
Skin Diseases, Viral
2
2018
4
0.140
Why?
Personal Satisfaction
1
2018
182
0.140
Why?
Evidence-Based Medicine
2
2018
676
0.130
Why?
Gloves, Surgical
1
1996
3
0.130
Why?
Gloves, Protective
1
1996
2
0.130
Why?
Latex
1
1996
9
0.130
Why?
Rubber
1
1996
8
0.130
Why?
Patient Acceptance of Health Care
2
2019
679
0.130
Why?
Cells, Cultured
13
2011
3896
0.130
Why?
Bronchial Hyperreactivity
1
1996
95
0.130
Why?
Dermatitis, Occupational
1
1996
13
0.130
Why?
Histamine H1 Antagonists
2
2006
33
0.130
Why?
Chemokines, CC
3
2006
28
0.130
Why?
Primary Health Care
2
2016
1512
0.130
Why?
Receptors, Cytokine
2
2010
33
0.130
Why?
Clinical Decision-Making
1
2018
267
0.120
Why?
Milk Proteins
1
2015
36
0.120
Why?
Ambulatory Care
1
2019
478
0.120
Why?
T-Lymphocyte Subsets
2
2011
383
0.120
Why?
Milk Hypersensitivity
1
2015
22
0.120
Why?
Gene Expression Profiling
4
2011
1523
0.120
Why?
Hydrotherapy
1
2014
8
0.120
Why?
Patient Care Planning
1
2015
139
0.120
Why?
Patient-Centered Care
2
2018
474
0.120
Why?
Infant Formula
1
2015
74
0.120
Why?
Risk Factors
8
2015
8642
0.120
Why?
Algorithms
3
2018
1489
0.120
Why?
Skin Tests
3
2012
123
0.120
Why?
Comorbidity
5
2018
1457
0.110
Why?
Aged
13
2019
19122
0.110
Why?
HLA-B7 Antigen
1
2013
7
0.110
Why?
Recombinant Proteins
6
2006
1237
0.110
Why?
Network Meta-Analysis
2
2023
15
0.110
Why?
Dose-Response Relationship, Drug
5
2020
1857
0.110
Why?
Lipids
1
2017
586
0.110
Why?
Young Adult
10
2019
10498
0.110
Why?
Health Status
1
2018
722
0.110
Why?
Logistic Models
4
2019
1839
0.110
Why?
Cholecalciferol
1
2013
47
0.110
Why?
Drug Administration Schedule
4
2020
719
0.100
Why?
RNA, Messenger
9
2007
2563
0.100
Why?
Interferon Regulatory Factor-2
1
2011
4
0.100
Why?
Research Design
1
2018
930
0.100
Why?
Vitamins
1
2013
151
0.100
Why?
Immunity, Cellular
1
2013
249
0.100
Why?
Vitamin D
2
2013
340
0.100
Why?
Physical Therapy Modalities
1
2014
265
0.100
Why?
Mice, Transgenic
3
2011
1955
0.100
Why?
Signal Transduction
2
2023
4525
0.100
Why?
Polymorphism, Single Nucleotide
7
2011
1901
0.100
Why?
CD4-Positive T-Lymphocytes
3
2010
965
0.090
Why?
Guideline Adherence
1
2015
492
0.090
Why?
Pharmaceutical Vehicles
2
2008
11
0.090
Why?
Glucocorticoids
2
2013
535
0.090
Why?
Th1-Th2 Balance
1
2010
10
0.090
Why?
JNK Mitogen-Activated Protein Kinases
1
2011
144
0.090
Why?
Histamine Antagonists
1
2010
20
0.090
Why?
Receptors, Chemokine
1
2010
43
0.090
Why?
Chickenpox Vaccine
1
2010
69
0.090
Why?
Therapies, Investigational
1
2010
14
0.090
Why?
Receptors, Interleukin-7
1
2010
25
0.090
Why?
Hypertension
1
2018
1058
0.090
Why?
Cardiovascular Diseases
2
2018
1729
0.090
Why?
Mice
9
2012
14928
0.090
Why?
Genetic Variation
2
2011
876
0.080
Why?
Age Factors
4
2019
2894
0.080
Why?
Dietary Supplements
1
2013
458
0.080
Why?
Herpesviridae Infections
1
2010
138
0.080
Why?
Disease Outbreaks
1
2012
309
0.080
Why?
Pediatrics
2
2015
981
0.080
Why?
Adjuvants, Immunologic
3
2004
206
0.080
Why?
Aged, 80 and over
6
2019
6357
0.080
Why?
Drug Therapy, Combination
3
2015
955
0.080
Why?
Coal Tar
1
2008
2
0.080
Why?
Keratolytic Agents
1
2008
5
0.080
Why?
Oligonucleotide Array Sequence Analysis
3
2011
744
0.080
Why?
Cell Degranulation
1
2008
39
0.080
Why?
Environmental Exposure
1
2012
377
0.080
Why?
Pyroglyphidae
2
2022
17
0.080
Why?
Phenotype
4
2023
2815
0.080
Why?
CD8-Positive T-Lymphocytes
1
2013
691
0.080
Why?
Irritants
1
2008
41
0.080
Why?
Basophils
1
2008
64
0.080
Why?
Quality Improvement
1
2016
953
0.080
Why?
Dosage Forms
1
2008
10
0.080
Why?
United Kingdom
2
2019
227
0.080
Why?
Emergency Service, Hospital
1
2019
1812
0.080
Why?
Polymorphism, Genetic
1
2011
617
0.080
Why?
S100 Proteins
1
2008
38
0.080
Why?
Mast Cells
1
2008
117
0.070
Why?
Combined Modality Therapy
3
2014
1127
0.070
Why?
Reference Values
2
2019
748
0.070
Why?
Cathelicidins
4
2010
38
0.070
Why?
Clinical Protocols
1
2008
234
0.070
Why?
Protein Precursors
1
2007
119
0.070
Why?
Drug Combinations
3
2020
287
0.070
Why?
Macrophage Inflammatory Proteins
1
2006
12
0.070
Why?
Herpesvirus 3, Human
1
2010
380
0.070
Why?
Immunohistochemistry
6
2010
1634
0.070
Why?
Virus Replication
2
2006
393
0.070
Why?
Patient Dropouts
1
2007
66
0.070
Why?
Cost-Benefit Analysis
3
2018
544
0.070
Why?
Disease Susceptibility
2
2020
316
0.070
Why?
Lymphocyte Activation
3
2010
1042
0.070
Why?
Nonprescription Drugs
1
2007
68
0.070
Why?
Receptors, Lymphocyte Homing
1
2006
15
0.070
Why?
Antibodies, Anti-Idiotypic
1
2006
54
0.070
Why?
Proteins
2
2010
915
0.070
Why?
Tumor Necrosis Factor-alpha
1
2011
1138
0.060
Why?
Immunoglobulins
2
2005
143
0.060
Why?
Gene Frequency
3
2013
483
0.060
Why?
Thiazoles
1
2006
110
0.060
Why?
Thyroid Diseases
1
2005
30
0.060
Why?
Models, Immunological
1
2005
92
0.060
Why?
Immunoglobulin G
2
2023
776
0.060
Why?
Academies and Institutes
1
2004
44
0.060
Why?
Hyaluronic Acid
1
2006
189
0.060
Why?
Resorcinols
1
2023
4
0.060
Why?
Interleukins
1
2006
236
0.060
Why?
Patient Care Team
1
2008
515
0.060
Why?
Stilbenes
1
2023
36
0.060
Why?
Lactams
2
1995
18
0.060
Why?
Statistics, Nonparametric
2
2019
387
0.060
Why?
Acute Disease
6
2008
915
0.060
Why?
Membrane Glycoproteins
1
2006
429
0.060
Why?
Janus Kinase 1
1
2023
23
0.060
Why?
Interleukin-10
1
2005
297
0.060
Why?
Leukocyte Count
2
1995
292
0.060
Why?
STAT Transcription Factors
1
2023
13
0.060
Why?
Interleukin-11
1
2003
9
0.050
Why?
Prednisone
2
1994
231
0.050
Why?
Risk
2
2018
815
0.050
Why?
Patient Compliance
1
2007
524
0.050
Why?
Caregivers
2
2023
712
0.050
Why?
Prognosis
3
2018
3335
0.050
Why?
Dermatophagoides pteronyssinus
1
2022
3
0.050
Why?
Prospective Studies
2
2020
6232
0.050
Why?
Conflict of Interest
1
2004
119
0.050
Why?
Fibronectins
1
2023
108
0.050
Why?
Interleukin-17
1
2003
104
0.050
Why?
Respiratory Sounds
1
2023
111
0.050
Why?
Clinical Trials, Phase II as Topic
1
2022
59
0.050
Why?
Lymphoma
2
2018
178
0.050
Why?
Granuloma, Respiratory Tract
1
2002
12
0.050
Why?
Leukocytes, Mononuclear
3
2013
496
0.050
Why?
Immunotherapy
1
2006
474
0.050
Why?
Insurance, Physician Services
1
2002
3
0.050
Why?
Clinical Trials, Phase III as Topic
1
2022
82
0.050
Why?
Baths
1
2022
17
0.050
Why?
Langerhans Cells
1
2001
11
0.050
Why?
3',5'-Cyclic-AMP Phosphodiesterases
1
2001
12
0.050
Why?
Eosinophils
2
1995
281
0.050
Why?
Disease Models, Animal
1
2011
3545
0.050
Why?
North America
1
2022
259
0.050
Why?
Ceramides
1
2022
94
0.050
Why?
Time Factors
2
2007
6141
0.050
Why?
Interleukin-15
1
2002
75
0.050
Why?
Longitudinal Studies
2
2019
2389
0.050
Why?
Diet
2
2022
1076
0.050
Why?
Claudin-1
2
2011
21
0.050
Why?
Gene Expression
3
2007
1423
0.050
Why?
Beryllium
1
2002
146
0.050
Why?
Bayes Theorem
1
2022
331
0.050
Why?
Placebos
1
2021
198
0.050
Why?
Monocyte Chemoattractant Proteins
1
2000
8
0.040
Why?
Health Expenditures
1
2002
171
0.040
Why?
Enzyme-Linked Immunosorbent Assay
3
2011
797
0.040
Why?
Injection Site Reaction
1
2020
3
0.040
Why?
Markov Chains
2
2015
114
0.040
Why?
Risk Assessment
2
2019
2976
0.040
Why?
Chemokines, CXC
2
2003
58
0.040
Why?
Fatty Acids
1
2022
385
0.040
Why?
Leg Dermatoses
1
2019
1
0.040
Why?
Scalp Dermatoses
1
2019
2
0.040
Why?
Bronchoalveolar Lavage Fluid
3
2002
590
0.040
Why?
Foot Dermatoses
1
2019
4
0.040
Why?
Buttocks
1
2019
10
0.040
Why?
Facial Dermatoses
1
2019
14
0.040
Why?
Hand Dermatoses
1
2019
7
0.040
Why?
Genitalia
1
2019
28
0.040
Why?
Biopsy
4
2007
1046
0.040
Why?
Smallpox Vaccine
2
2011
22
0.040
Why?
Infection Control
1
2020
135
0.040
Why?
Genetic Association Studies
2
2011
344
0.040
Why?
Haplotypes
2
2011
455
0.040
Why?
Torso
1
2019
30
0.040
Why?
Interleukin-16
1
1998
6
0.040
Why?
Autoantigens
1
2001
397
0.040
Why?
Dysbiosis
1
2020
146
0.040
Why?
Acetamides
1
2018
25
0.040
Why?
Canada
1
2020
322
0.040
Why?
Association
1
2018
11
0.040
Why?
Thalidomide
1
2018
28
0.040
Why?
Skin Diseases, Bacterial
1
2018
22
0.040
Why?
Phthalic Acids
1
2018
28
0.040
Why?
Arm
1
2019
104
0.040
Why?
Rhinitis, Allergic, Seasonal
1
2018
32
0.040
Why?
Colony Count, Microbial
1
2018
111
0.040
Why?
Pilot Projects
2
1995
1375
0.040
Why?
Medicaid
1
2002
409
0.040
Why?
Age Distribution
1
2018
340
0.040
Why?
Herpesvirus 2, Human
2
2009
27
0.040
Why?
Sex Distribution
1
2018
335
0.040
Why?
Fundoplication
1
1997
51
0.040
Why?
Immune System
1
2018
172
0.040
Why?
United States Food and Drug Administration
1
2018
172
0.040
Why?
Proteomics
1
2023
844
0.040
Why?
Quinazolines
1
2018
240
0.040
Why?
Peak Expiratory Flow Rate
2
1993
33
0.040
Why?
Psychiatric Status Rating Scales
1
2019
484
0.030
Why?
Monocytes
2
2002
503
0.030
Why?
Educational Status
1
2019
412
0.030
Why?
Texas
2
2008
187
0.030
Why?
Forced Expiratory Volume
2
1997
476
0.030
Why?
Psychometrics
1
2019
608
0.030
Why?
Health Occupations
1
1996
28
0.030
Why?
Rhinitis, Allergic
1
2016
35
0.030
Why?
Interleukin-12
1
1996
110
0.030
Why?
Feasibility Studies
1
2018
746
0.030
Why?
Sleep
1
2021
631
0.030
Why?
Penicillins
1
1995
52
0.030
Why?
Genetic Linkage
1
1996
297
0.030
Why?
Whey Proteins
1
2015
5
0.030
Why?
Pyridines
1
2018
426
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2010
928
0.030
Why?
Multivariate Analysis
1
2019
1435
0.030
Why?
Gastroesophageal Reflux
1
1997
233
0.030
Why?
Intraoperative Complications
1
1996
124
0.030
Why?
Attention Deficit Disorder with Hyperactivity
1
2018
364
0.030
Why?
Cohort Studies
2
2015
4904
0.030
Why?
Socioeconomic Factors
1
2019
1081
0.030
Why?
Legionellosis
1
1994
2
0.030
Why?
Legionnaires' Disease
1
1994
4
0.030
Why?
Polymerase Chain Reaction
2
2010
999
0.030
Why?
Dermatitis, Irritant
2
2004
11
0.030
Why?
Long-Term Care
1
2015
76
0.030
Why?
Pneumonia, Pneumocystis
1
1994
26
0.030
Why?
Nebulizers and Vaporizers
1
1995
78
0.030
Why?
Milk
1
2015
124
0.030
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1995
140
0.030
Why?
Antigens
1
1996
318
0.030
Why?
ROC Curve
1
2015
447
0.030
Why?
Methylprednisolone
1
1994
82
0.030
Why?
Case-Control Studies
2
2013
3015
0.030
Why?
Respiratory Physiological Phenomena
1
1993
29
0.030
Why?
Immunologic Memory
1
1996
313
0.030
Why?
Sex Factors
1
2019
1721
0.030
Why?
Laparoscopy
1
1997
387
0.030
Why?
Chemokine CXCL10
2
2009
34
0.030
Why?
Anaphylaxis
1
1996
148
0.030
Why?
Healthcare Disparities
1
2019
480
0.030
Why?
Mice, Inbred BALB C
2
2006
1153
0.030
Why?
Interdisciplinary Communication
1
2014
185
0.030
Why?
Genotype
1
2018
1780
0.030
Why?
Respiratory System
1
1993
138
0.030
Why?
Mice, Knockout
2
2011
2585
0.030
Why?
Chemokines
2
2006
213
0.030
Why?
Cockroaches
1
2012
21
0.030
Why?
Treatment Failure
1
1993
332
0.030
Why?
Reproducibility of Results
1
2019
2799
0.030
Why?
Haptens
1
1992
21
0.030
Why?
Patient Care
1
2013
103
0.030
Why?
Cats
1
2012
205
0.020
Why?
Vaccinia
1
2011
18
0.020
Why?
Microbiota
1
2019
648
0.020
Why?
Family
1
2015
591
0.020
Why?
Models, Theoretical
1
2015
517
0.020
Why?
Enterocolitis, Pseudomembranous
1
1991
25
0.020
Why?
Dogs
1
2012
340
0.020
Why?
Lung Diseases
1
1997
703
0.020
Why?
Receptors, Interferon
1
2011
47
0.020
Why?
Predictive Value of Tests
1
2015
1812
0.020
Why?
Fluorescent Antibody Technique
1
2011
396
0.020
Why?
Hospitalization
1
2019
1755
0.020
Why?
Antigens, Viral
1
2010
176
0.020
Why?
Mutation
2
2011
3350
0.020
Why?
Incidence
1
1996
2318
0.020
Why?
Chemokine CCL27
1
2009
1
0.020
Why?
Chemokine CCL17
1
2009
4
0.020
Why?
Health Care Costs
2
2003
381
0.020
Why?
Lung
1
2002
3595
0.020
Why?
Age of Onset
1
2010
449
0.020
Why?
DNA Mutational Analysis
1
2010
372
0.020
Why?
Interferon-beta
1
2009
79
0.020
Why?
Skin Physiological Phenomena
1
2008
26
0.020
Why?
Herpesvirus 1, Human
1
2009
77
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
107
0.020
Why?
Glyceraldehyde-3-Phosphate Dehydrogenases
1
2007
14
0.020
Why?
Health Personnel
1
2013
574
0.020
Why?
Fluticasone
1
2007
87
0.020
Why?
Chemokine CCL20
1
2006
4
0.020
Why?
In Situ Hybridization
2
1998
292
0.020
Why?
Androstadienes
1
2007
97
0.020
Why?
Thiazolidines
1
2006
7
0.020
Why?
Obesity
1
2018
2524
0.020
Why?
Toll-Like Receptor 3
1
2006
26
0.020
Why?
Antigens, Differentiation, T-Lymphocyte
1
2006
84
0.020
Why?
Vitis
1
2006
38
0.020
Why?
Antibodies, Viral
1
2009
522
0.020
Why?
Apoptosis
1
1995
2366
0.020
Why?
Europe
1
2006
336
0.020
Why?
Genomics
1
2010
641
0.020
Why?
Analysis of Variance
1
2008
1229
0.020
Why?
Product Surveillance, Postmarketing
1
2005
63
0.020
Why?
Erythema
1
2004
25
0.020
Why?
Infant, Newborn
1
2015
5040
0.010
Why?
Neoplasms, Experimental
1
2005
151
0.010
Why?
Antigens, Neoplasm
1
2006
222
0.010
Why?
Case Management
1
2004
62
0.010
Why?
Rats
1
2012
4973
0.010
Why?
DNA, Viral
1
2006
349
0.010
Why?
Inflammation Mediators
1
2006
476
0.010
Why?
Collagen Type III
1
2003
18
0.010
Why?
Retreatment
1
2003
67
0.010
Why?
Dendritic Cells
1
2006
436
0.010
Why?
Societies, Medical
1
2006
678
0.010
Why?
Collagen Type I
1
2003
108
0.010
Why?
Cell Line
1
2008
2645
0.010
Why?
Genes, T-Cell Receptor beta
1
2002
18
0.010
Why?
Calcium
1
2008
1104
0.010
Why?
Administration, Oral
1
2004
730
0.010
Why?
Immunophenotyping
1
2003
276
0.010
Why?
Transforming Growth Factor beta1
1
2003
154
0.010
Why?
Insurance, Health, Reimbursement
1
2003
88
0.010
Why?
Base Sequence
1
2006
2119
0.010
Why?
Cooperative Behavior
1
2004
383
0.010
Why?
Health Services
1
2003
103
0.010
Why?
Biopsy, Needle
1
2002
183
0.010
Why?
Cell Differentiation
1
2008
1700
0.010
Why?
Patient Satisfaction
1
2004
580
0.010
Why?
Chemotactic Factors, Eosinophil
1
2000
6
0.010
Why?
Receptors, Antigen, T-Cell, alpha-beta
1
2002
309
0.010
Why?
Chemokine CCL11
1
2000
22
0.010
Why?
Up-Regulation
1
2003
812
0.010
Why?
Transforming Growth Factor beta
1
2003
448
0.010
Why?
Odds Ratio
1
2003
957
0.010
Why?
Drug Prescriptions
1
2002
239
0.010
Why?
Receptors, Interleukin-5
1
1998
5
0.010
Why?
Receptors, Interleukin-12
1
1998
6
0.010
Why?
Receptors, Interleukin-4
1
1998
15
0.010
Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
1998
12
0.010
Why?
Flow Cytometry
1
2002
1084
0.010
Why?
Retrospective Studies
2
2006
12548
0.010
Why?
Amino Acid Sequence
1
2002
1990
0.010
Why?
Cell Movement
1
2002
866
0.010
Why?
Molecular Sequence Data
1
2002
2796
0.010
Why?
Models, Biological
1
2004
1636
0.010
Why?
Colorado
1
2006
4089
0.010
Why?
Respiratory Function Tests
1
1997
523
0.010
Why?
Immunocompetence
1
1994
40
0.010
Why?
Interleukin-5
1
1994
30
0.010
Why?
Methacholine Chloride
1
1993
47
0.010
Why?
Bronchial Provocation Tests
1
1993
53
0.010
Why?
Fatal Outcome
1
1994
285
0.010
Why?
Aerosols
1
1993
151
0.010
Why?
Interleukin-8
1
1993
238
0.010
Why?
Macrophage Activation
1
1993
164
0.010
Why?
Bronchi
1
1993
243
0.010
Why?
Administration, Inhalation
1
1993
641
0.010
Why?
Neoplasms
1
2005
2106
0.010
Why?
Cell Survival
1
1995
1022
0.010
Why?
Enterotoxins
1
1991
88
0.010
Why?
Macrophages, Alveolar
1
1993
351
0.010
Why?
Antibodies, Bacterial
1
1991
119
0.010
Why?
Immunoglobulins, Intravenous
1
1991
121
0.010
Why?
Interleukin-1
1
1993
970
0.010
Why?
Transcription, Genetic
1
1993
1317
0.000
Why?
Boguniewicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)